Zoledronic acid - Pharm-SintezAlternative Names: Zoledronic acid monohydrate; Zoledronic acid monohydrate - Pharm Sintez
Latest Information Update: 24 Oct 2015
At a glance
- Originator Pharm-Sintez
- Class Antineoplastics; Bisphosphonates; Calcium regulators; Imidazoles; Osteoporosis therapies; Small molecules
- Mechanism of Action Bone resorption factor inhibitors; Geranylgeranyltransferase inhibitors; Osteoclast inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypercalcaemia; Multiple myeloma; Osteoporosis; Postmenopausal osteoporosis; Solid tumours